Lv5
970 积分 2023-11-28 加入
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
14天前
已完结
From backstage to the spotlight: γδT cells in cancer
30天前
已完结
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: a comprehensive review
1个月前
已完结
Cancer immunotherapy by γδ T cells
1个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
2个月前
已完结
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosis
2个月前
已完结
γδ T cells as critical anti-tumor immune effectors
3个月前
已完结
Alterations of T-cell-mediated immunity in acute myeloid leukemia
3个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
4个月前
已完结
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors
5个月前
已完结
皖公网安备34019202002308
